Eddie Martucci, the co-founder of Akili Interactive, discusses his goals to reshape medicine through innovative video game treatments designed for ADHD. He shares his journey from biochemistry to merging neuroscience with video game development. Eddie emphasizes his groundbreaking products like EndeavorRx and EndeavorOTC, the first ADHD treatments via immersive video games. He is changing medical norms through Akili Interactive, combining scientific rigor with gaming allure. Dive into Akili’s evolution, Eddie’s forward-looking vision, and the positive healthcare impact, focusing on cognitive functioning and the anterior cingulate cortex. He is highlighting the potential of his patented technology, ensuring precise activation of user engagement for healthcare empowerment.
KEY MOMENTS
Introduction:
Eddie Martucci, co-founder of Akili, discusses the vision of transforming medicine through digital therapeutics.
Eddie’s Background: Eddie shares his background in healthcare, biochemistry, and molecular biophysics.
Inspiration Behind Akili: The team at Akili was inspired by the technological advancements around 2009-2010, particularly in smartphone capabilities.
Focus on Cognitive Functioning: Akili focuses on cognitive functioning, addressing attention-related issues, and processing information.
Distinguishing Akili’s Products: Eddie explains how Akili’s products differ from traditional video games.
Focus Score Metric: Eddie introduces the ‘Focus Score,’ a cognitive metric in Endeavor OTC.
Future of Digital Therapeutics: Eddie predicts a future where digital therapeutics become commonplace alongside traditional medications.